• Nenhum resultado encontrado

Inhibition of mesothelin as a novel strategy for targeting cancer cells.

N/A
N/A
Protected

Academic year: 2016

Share "Inhibition of mesothelin as a novel strategy for targeting cancer cells."

Copied!
11
0
0

Texto

Loading

Referências

Documentos relacionados

Lectin binding properties of human breast cancer cell lines and human milk with particular reference for helix

High PD-L1 expressing basal breast cancer cell lines (N = 12) demonstrate higher levels of STAT1 expression and lower levels of IRF2BP2 compared to low PD-L1 expressing cell lines (N

While the expression of MUC16 protein in 3T3 cells was clearly linked to hallmarks of trans- formation, some fully transformed ovarian cancer cell lines lack MUC16 expression

Using pancreatic cancer cell lines with or without expressing mutated K-ras , we demonstrated that the inhibition of endogenous PKC activity sensitized human pancreatic cancer

Increased expression of Rev3 in human breast epithelial cancer cell lines compared to non- neoplastic human breast epithelial cells MCF-12A, and in human breast tumors compared

To analyse the expression of miR-196a, qRT-PCR was performed in Four human pancreatic cancer cell lines (PANC-1, Capan-2, BxPC-3 and SW1990) and an immortalized pancreatic

Compound 2 was screened in vitro in seven human cancer cell lines, MCF7 and EVSAT (mammary cancers), WiDr (colon cancer), IGROV (ovarian cancer), M19 (melanoma), MEL A498

High expression levels of TP have also been observed in lung, bladder and prostate cancer cell lines, leading to increased cell proliferation, migration and invasion